Annals of Hematology

Search all Annals of Hematology articles

Volume 96, Issue 12

December 2017

23 articles in this issue

The progress and current status of immunotherapy in acute myeloid leukemia
Dan Yang
Xiuqun Zhang
Yanli Xu
Review Article 28 October 2017 Pages: 1965 - 1982
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
Samah Nassereddine
Coen J. Lap
Imad Tabbara
Review Article 31 October 2017 Pages: 1983 - 1991
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Gabriele Nagel
D. Weber
German-Austrian AML Study Group (AMLSG)
Original Article Open access 31 October 2017 Pages: 1993 - 2003
Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide
Jinxiao Hou
Shuye Wang
Xiaoxia Li
Original Article 22 September 2017 Pages: 2005 - 2013
The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study
Cesar Homero Gutiérrez-Aguirre
Juan Antonio Flores-Jiménez
David Gómez-Almaguer
Original Article 13 October 2017 Pages: 2015 - 2024
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry
Brett L. Houston
Jennifer Jayakar
Rena Buckstein
Original Article 03 October 2017 Pages: 2025 - 2029
Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis
Nan Yang
Jinqiu Chen
Wanggang Zhang
Original Article 30 September 2017 Pages: 2031 - 2043
Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura
Gürkan Bal
Depré Fabian
Abdulgabar Salama
Original Article 30 September 2017 Pages: 2045 - 2056
Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma
Yutaka Tsutsumi
Chie Nakayama
Takanori Teshima
Original Article Open access 22 September 2017 Pages: 2057 - 2061
Clinicopathological features of primary splenic follicular lymphoma
Joji Shimono
Hiroaki Miyoshi
Koichi Ohshima
Original Article 03 October 2017 Pages: 2063 - 2070
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
Beatrice Anna Zannetti
Paola Tacchetti
Elena Zamagni
Original Article 24 October 2017 Pages: 2071 - 2078
High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma
Liang Wang
Jing-hua Wang
Zhong-jun Xia
Original Article 05 September 2017 Pages: 2079 - 2088
At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment
Kai-ni Shen
Jun Feng
Jian Li
Original Article 27 September 2017 Pages: 2089 - 2094
Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation
C. S. Michel
D. Teschner
Markus P. Radsak
Original Article 17 September 2017 Pages: 2095 - 2101
VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment
Mateusz Nowicki
Agnieszka Wierzbowska
Anna Szmigielska-Kapłon
Original Article 27 September 2017 Pages: 2103 - 2112
Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study
Kensuke Matsuda
Kazuki Taoka
Mineo Kurokawa
Letter to the Editor 02 November 2017 Pages: 2113 - 2115
Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab
Mitsuhiro Akiyama
Hidekata Yasuoka
Tsutomu Takeuchi
Letter to the Editor 01 September 2017 Pages: 2117 - 2119
Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab
Bonnie Kho
Howard H. N. Wong
Yok-Lam Kwong
Letter to the Editor 21 August 2017 Pages: 2121 - 2123
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant
Bhagirathbhai Dholaria
Raj J. Patel
Vivek Roy
Letter to the Editor 06 September 2017 Pages: 2125 - 2126
Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
Haigang Shao
Qian Yang
Jinlan Pan
Letter to the Editor 24 August 2017 Pages: 2127 - 2129
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression
Xiaoxue Yang
Heng Xu
Li Yang
Letter to the Editor Open access 22 August 2017 Pages: 2131 - 2133
Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations
Prabhakar Kedar
Vaishali Parmar
Manisha Madkaikar
Letter to the Editor 07 September 2017 Pages: 2135 - 2139
Cytogenetic evidence for the clonal hematopoietic cell origin of alveolar macrophages in myelodysplastic syndrome-associated pulmonary alveolar proteinosis
Yuya Nagai
Chiyuki Kishimori
Hitoshi Ohno
Letter to the Editor 28 August 2017 Pages: 2141 - 2143

Volume 96, Issue 12

The progress and current status of immunotherapy in acute myeloid leukemia

The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study

A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry

Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis

Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura

Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma

Clinicopathological features of primary splenic follicular lymphoma

Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma

High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation

VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment

Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study

Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab

Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)

Rare gene variants in a patient with azathioprine-induced lethal myelosuppression

Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations

Cytogenetic evidence for the clonal hematopoietic cell origin of alveolar macrophages in myelodysplastic syndrome-associated pulmonary alveolar proteinosis

Journal navigation